

Can't find Angeliq 0.25/0.5 28 Day? Here are FDA-approved alternatives your doctor can prescribe, including how they compare on effectiveness, cost, and availability.
If you've been taking Angeliq 0.25/0.5 28 Day and suddenly can't fill your prescription, the last thing you want is to go without hormone replacement therapy. Menopause symptoms like hot flashes, night sweats, and vaginal dryness can come back quickly — sometimes within days of stopping treatment.
The good news is that several other FDA-approved combination HRT medications work in a similar way. In this article, we'll explain how Angeliq works and walk you through the best alternatives your doctor can consider if Angeliq is hard to find or too expensive.
Angeliq is a brand-name tablet made by Bayer that combines two hormones:
It's prescribed for women who still have a uterus and experience moderate to severe hot flashes due to menopause. You take one tablet daily with no breaks — it's a continuous combined regimen.
During menopause, the ovaries produce significantly less estrogen. This drop triggers vasomotor symptoms (hot flashes, night sweats) and can cause vaginal tissue to thin and dry out. Angeliq replaces estrogen to relieve these symptoms.
The Drospirenone component serves two purposes. First, it provides endometrial protection — without a progestin, taking estrogen alone can lead to dangerous overgrowth of the uterine lining. Second, Drospirenone is derived from Spironolactone and has antimineralocorticoid properties, meaning it helps prevent the bloating and fluid retention that many women experience on estrogen therapy.
Prempro is one of the most widely prescribed combination HRT medications in the United States. It combines conjugated estrogens (derived from natural sources) with Medroxyprogesterone Acetate (MPA), a synthetic progestin.
Key differences from Angeliq:
Best for: Women who need a reliable, affordable HRT option and aren't experiencing significant bloating issues on other formulations.
Activella combines bioidentical Estradiol (the same estrogen in Angeliq) with Norethindrone Acetate, a different progestin. Like Angeliq, it's taken as one tablet daily in a continuous regimen.
Key differences from Angeliq:
Best for: Women who respond well to Estradiol-based HRT and want a more affordable, easier-to-find option.
Climara Pro is a transdermal (skin) patch that delivers Estradiol and Levonorgestrel (a progestin) through the skin over the course of a week. You apply a new patch every 7 days.
Key differences from Angeliq:
Best for: Women who prefer a non-oral option or who have risk factors that make transdermal delivery safer (e.g., history of blood clots, obesity, or liver concerns).
Bijuva is a newer combination HRT that pairs bioidentical Estradiol with bioidentical Progesterone (not a synthetic progestin). It's the first FDA-approved product to combine these two bioidentical hormones in a single capsule.
Key differences from Angeliq:
Best for: Women who want a bioidentical hormone combination and are willing to pay a brand-name price for it.
If Angeliq is unavailable, bring these alternatives to your appointment (or call your doctor's office). Key questions to ask:
Most women can transition between combination HRT products smoothly, though it may take a few weeks for your body to adjust to a new formulation.
Angeliq 0.25/0.5 28 Day is a great medication, but it's not the only option for managing menopause symptoms. If you can't find it, don't suffer in silence — there are effective alternatives with proven track records. Talk to your doctor, and use Medfinder to check availability of any medication in your area.
For more on the current Angeliq supply situation, read our 2026 shortage update.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.